Minimizing red blood cell contamination while isolating mononuclear cells from whole blood: The next step for the treatment of severe hemolytic disease of the fetus/newborn

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 1012-1016

  Lam, Garrett K ^a   Subramanyam, Lalitha ^a   Orton, Susan ^a   Farb, Rod ^a   Moise Jr , Kenneth J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CB #7516 ^*  (United States)

Author keywords

Hemolytic disease of the fetus newborn; Monocytes; Paternal leukocyte therapy; Red blood cell alloimmunization; Rhesus disease

Indexed keywords

HLA ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ANTIBODY RESPONSE; ARTICLE; BLOOD COMPONENT THERAPY; CELL COUNT; CLINICAL ARTICLE; CONTAMINATION; ERYTHROCYTE; ERYTHROCYTE ALLOIMMUNIZATION; FLOW CYTOMETRY; HEMOLYSATE; HUMAN; HUMAN CELL; LEUKAPHERESIS; MONONUCLEAR CELL; NEWBORN HEMOLYTIC DISEASE; PATERNAL LEUKOCYTE THERAPY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHESUS INCOMPATIBILITY;

EID: 0242509131     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00813-5     Document Type: Article

References (17)

1. Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991; 265:3270-4.
2. Schumacher B, Niuse KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-50.
3. Neppert J, von Witzleben-Schurholz E, Zupanska B, et al. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn: Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN. Eur J Haematol 1999;63:120-5.
4. Faust A, Neppert J. Detection of antibodies specific for HLA-A, B, C, DR, DQ and DP by the erythrocyte antibody rosette inhibition and immune phagocytosis inhibition tests. J. Immunol Methods 1987; 102:71-5.
5. Wiener E, Mawas F, Dellow RA, Singh I, Rodeck CH. A major role of class 1 Fc gamma receptors in immunoglobulin G anti-D mediated red blood cell destruction by fetal mononuclear phagocytes. Obstet Gynecol 1995;86:157-62.
6. Shepard SL, Noble AL, Filbey D, Hadley AG. Inhibition of the monocyte chemiluminescent response to anti-D sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease a of the newborn. Vox Sang 1996;70:157-63.
7. Whitecar P, Farb R, Subramanyam L, Dorman K, Bagchee R, Moise K. Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn/fetus in a rabbit model. Am J Obstet Gynecol 2002;187:977-80.
8. Beer AE, Quebberman JF, Ayers JW, Haines RF. Major histocompatibility complex antigens: maternal and paternal immune response and chronic habitual abortion in humans. Am J Obstet Gynecol 1981;141:987-99.
9. Ficoll-Paque Plus and Ficoll-Paqne Research Grade [package instructions]. Sweden: Pharmacia Biotech; 2001.
10. Carp HJA, Toder V, Mashiach S, Nebel L, Serr DM. Recurrent miscarriage: a review of current concepts, immune mechanisms and results of treatment. Obstet Gynecol Surv 1990;45:657-67.
11. Dooren MC, van Kamp IL, Kanhai HH, Granvehorst JB, von dem Borne AE, Engelfreit CP. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn. Vox Sang 1993;65:55-8.
12. Neppert J, Pohl E, Mueller-Eckhardt C. Inhibition of immune phagocytosis by human sera with HLA A, B, C and DR but not with DQ or EM type reactivity. Vox Sang 1986;51:122-6.
13. McBride JA, O'Hoski P, Barnes CC, Spiak C, Blajchman MA. Rhesus allo-immunizacion following intensive plasma exchange. Transfusion 1983;23:352-4.
14. Ching EP, Poon MC, Neurath D, Ruether B. Red blood cell alloimmunization complicating plasma transfusion. Am J Clin Pathol 1991;96:201-2.
15. Reprotox. 2002. Available from: www.reprotox.org.
16. Levinsky N. Acidosis and alkalosis. In: Isselbacher K, Braunwald E, Wuilson J, et al, editors. Harrison's principles of internal medicine. New York: McGraw Hill; 1994. p. 259.
17. Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:55-72.